The Enterprise Value as of June 2026 (TTM) for Neurogene Inc. (NGNE) is 344.80M

According to Neurogene Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 344.80M. This represents a change of 21.44% compared to the average of 283.93M of the last 4 quarters.

Neurogene Inc. (NGNE) Historical Enterprise Value (quarterly & annually)

How has NGNE Enterprise Value performed in the past?

The mean historical Enterprise Value of Neurogene Inc. over the last ten years is 3.96B. The current 344.80M Enterprise Value has changed 770.87% with respect to the historical average. Over the past ten years (40 quarters), NGNE's Enterprise Value was at its highest in in the June 2020 quarter at 16.28B. The Enterprise Value was at its lowest in in the September 2022 quarter at 39.68M.

Neurogene Inc. (NGNE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Neurogene Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neurogene Inc. (NGNE) Average Enterprise Value

How has NGNE Enterprise Value performed in the past?

The current Enterprise Value of Neurogene Inc. (NGNE) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Neurogene Inc. (NGNE) Enterprise Value vs. Peers

How is NGNE’s Enterprise Value compared to its peers?

Neurogene Inc.’s Enterprise Value is greater than Lineage Cell Therapeutics, Inc. (283.06M), less than Ocugen, Inc. (411.05M), greater than Fulcrum Therapeutics, Inc. (142.29M), less than Autolus Therapeutics plc (364.21M), greater than ADC Therapeutics S.A. (323.90M), greater than Benitec Biopharma Inc. (109.56M), greater than Solid Biosciences Inc. (279.21M), greater than PureTech Health plc (189.76M), greater than Quantum-Si incorporated (154.79M), less than Alumis Inc. Common Stock (2.95B),

Build a custom stock screener for Neurogene Inc. (NGNE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neurogene Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neurogene Inc. (NGNE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neurogene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.